Showing results (131-140 of 267) with videos related to

Sort By:
Pageof 27
Journal of Experimental & Clinical Cancer Research : CR|September 8, 2023
Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascitesAntonio Hrvat, Mathias Schmidt, Bernd Wagner, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 25, 2014
Intraindividual right-left comparison of sonographic features in polycystic ovary syndrome (PCOS) diagnosisAngela Köninger, Laura Koch, Philippos Edimiris, et al.
The Lancet. Oncology|August 7, 2019
Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort studyMichael Höckel, Benjamin Wolf, Katja Schmidt, et al.
Human Reproduction (Oxford, England)|February 7, 2006
Determinants of emotional distress in women with polycystic ovary syndromeSigrid Elsenbruch, Sven Benson, Susanne Hahn, et al.
Frontiers in Endocrinology|December 11, 2020
CCN3 Signaling Is Differently Regulated in Placental Diseases Preeclampsia and Abnormally Invasive PlacentaLiyan Duan, Manuela Schimmelmann, Yuqing Wu, et al.
Breast Cancer (Tokyo, Japan)|January 13, 2022
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™-HER2-FISH workflowLisa Grüntkemeier, Aditi Khurana, Farideh Zamaniyan Bischoff, et al.
Reproductive Biology and Endocrinology : RB&E|March 29, 2018
Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot studyAngela Köninger, Annette Mathan, Pawel Mach, et al.
Gynecologic Oncology|November 16, 2010
The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancerMartin Heubner, Pauline Wimberger, Burkhardt Dahlmann, et al.
Archives of Gynecology and Obstetrics|May 16, 2015
Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsiaCahit Birdir, Katharina Janssen, Anca Daniela Stanescu, et al.
Cancers|May 1, 2020
Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer PatientsCorinna Keup, Markus Storbeck, Siegfried Hauch, et al.
Pageof 27